Latest Updates

NCPA cheered the U.S. Supreme Court's decision to hear an Arkansas case to decide whether ERISA preempts (supersedes) a state law that regulates pharmacy benefit managers — massive corporate middlemen who have operated in a regulatory no-man's land for decades.

A Joint Special Committee on Access to Quality Health Care and Insurance convened in Atlanta on January 7th to hear testimony from pharmacists, patients and physicians across the state of Georgia on how pharmacy benefit managers (PBMs) present challenging barriers for patients to gain access to needed medications.

Ohio officials have expressed they are not hearing from pharmacists – have a voice! View our Ohio Medicaid Reimbursement document to access talking points and resources for contacting your Ohio legislators to inform them about the importance of fair Medicaid reimbursement.

On December 6th, the Senate Finance Committee released an updated bipartisan version of S. 2543, the Prescription Drug Pricing Reduction Act (PDPRA), and included language to require pharmacy price concessions be included in negotiated price at the point of sale for Medicare Part D beginning in 2022. This language would also prohibit retroactive DIR fees and would allow positive post point-of-sale incentive payments for pharmacies in addition to establishing pharmacy quality metrics in 2022.

In honor of American Pharmacists Month, Chain Drug Review featured Steve Hoffart of Magnolia Pharmacy, a Good Neighbor Pharmacy, in its “Excellence in Pharmacy Practice” section: Independent makes a major difference in rural location.